ALPRAZOLAM EXTENDED-RELEASE is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Alprazolam.
| Product ID | 63629-1541_76f07536-e338-4984-ba2a-148ce9c5a92d |
| NDC | 63629-1541 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ALPRAZOLAM EXTENDED-RELEASE |
| Generic Name | Alprazolam |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-03-28 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077996 |
| Labeler Name | Bryant Ranch Prepack |
| Substance Name | ALPRAZOLAM |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Benzodiazepine [EPC],Benzodiazepines [CS] |
| DEA Schedule | CIV |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2007-03-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-28 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-03-28 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-28 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-09-15 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-28 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-28 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-28 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-28 |
| Inactivation Date | 2019-11-27 |
| Marketing Category | ANDA |
| Application Number | ANDA077996 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-28 |
| Inactivation Date | 2019-11-27 |
| Ingredient | Strength |
|---|---|
| ALPRAZOLAM | .5 mg/1 |
| SPL SET ID: | 5c921bf0-0a5a-4408-a3d7-b02f907aa321 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52959-965 | ALPRAZOLAM EXTENDED-RELEASE | ALPRAZOLAM EXTENDED-RELEASE |
| 63629-1541 | ALPRAZOLAM EXTENDED-RELEASE | ALPRAZOLAM EXTENDED-RELEASE |
| 0054-3068 | Alprazolam | Alprazolam |
| 0228-2027 | Alprazolam | Alprazolam |
| 0009-0029 | Xanax | alprazolam |
| 0009-0055 | Xanax | alprazolam |
| 0009-0057 | Xanax | alprazolam |
| 0009-0059 | Xanax | alprazolam |
| 0009-0066 | Xanax | alprazolam |
| 0009-0068 | Xanax | alprazolam |
| 0009-0090 | Xanax | alprazolam |
| 0009-0094 | Xanax | alprazolam |